Asker acquires AmberCell Solutions

Ellex team advised Asker Healthcare Group on its acquisition of AmberCell Solutions UAB through OneMed OÜ. Asker Healthcare Group is acquiring 100 per cent of the shares in AmberCell Solutions, a leading Baltic medtech solutions provider and distributor. AmberCell provides therapy- and procedure-specific packs and medical consumables through its integrated supply chain management platform, alongside medical products, technologies and clinical solutions across Lithuania, Latvia and Estonia. The company has 45 employees and generated revenue of approximately SEK 250m (EUR 22.6 m) in the past year.

Ellex teams from all three Baltic offices carried out legal due diligence, while Ellex in Estonia is also advising on competition clearance. The acquisition remains subject to regulatory approval and is expected to be completed in the fourth quarter of 2026.

Asker Healthcare Group was advised by the Ellex Baltic team: Paulius Gruodis, Arvydas Grušeckas, Jaanus Ikla, Šarūnas Keserauskas, Andra Lapė, Gerda Liik, Martin Mäesalu, Kaspars Oļševskis, Sarmis Spilbergs, Rūta Tamulionytė, Miikael Tuus, and other colleagues.

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. The group has more than 5,000 employees in 19 countries and revenues amounting to SEK 18 billion (EUR 1, 63 billion). The company is headquartered in Sweden.